Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of the Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE)

NCT05442489 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS

Last updated 2026-02-18

No results posted yet for this study

Summary

Expanded access tothe GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis is safe and effective in the treatment of thoracoabdominal and pararenal aneurysms.

Conditions

  • Thoracoabdominal Aneurysm

Interventions

DEVICE

GORE Excluder Thoracoabdominal Branch Endoprosthesis

TEVAR

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05442489 on ClinicalTrials.gov